“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

Bayer today announced topline results of the Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational gadolinium-based contrast agent (GBCA) for use in magnetic ...

Bayer has joined its peers among European drugmakers ... Among pharma watchers, all eyes are currently on key pharma prospects Kerendia (finerenone) for chronic kidney disease and prostate cancer ...

To us, anyway. Over 50 seasons, “Saturday Night Live” has introduced crystal gravy, robot insurance and countless other demented goods and services. Share your favorites in the comments.

Leverkusen also became the headquarters for the I.G.'s pharmaceutical sales association, and the Bayer Cross was used as the trademark for all of the I.G.'s pharmaceutical products. In the early ...

Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...

The Company is engaged in `Agri Care' business which primarily includes manufacture sale and distribution of insecticides fungicides herbicide and various other agrochemical products ... of Bayer ...

We’re all tolerant people; we all get frustrated at a bad call ... These do not influence editorial content, though Vox Media ...

GE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on ...

A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...